LCTX

LINEAGE CELL THERAPEUTICS INC

Healthcare | Micro Cap

-$0.02

EPS Forecast

$2.2

Revenue Forecast

Announcing earnings for the quarter ending 2026-09-30 soon

Market expectations

EPS Expectation:

-$0.02

Revenue Expectation:

$2.2

EPS Surprise Expectation:

-$0.003

Revenue Surprise Expectation:

-$1

Post-release price volatility - High

Post-release Overnight Move:

±8.1%

Post-release 1-week Move:

±

Expected price impact

If company results match EPS & revs consensus exactly:

1.5%

If company results match Proximilar expectations exactly:

0.5%

Earnings volatility

EPS standard deviation:

$0.04

Revenue standard deviation:

$7

As % of share price:

3.47% EXTREME UNCERTAINTY

As % of market cap:

2.64% HIGH